Ally Bridge Group (NY) LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$120.2B
Holdings
24
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VRNAVERONA PHARMA PLC | 160,701 | $15.2B | 12.65% | |
| 2 | SLNOSOLENO THERAPEUTICS INC | 178,819 | $15.0B | 12.47% | |
| 3 | LENZLENZ THERAPEUTICS INC | 343,322 | $10.1B | 8.37% | |
| 4 | MRUSMERUS N V | 140,208 | $7.4B | 6.14% | |
| 5 | RAREULTRAGENYX PHARMACEUTICAL IN | 1,600 | $5.8B | 4.84% | |
| 6 | ELVNENLIVEN THERAPEUTICS INC | 281,394 | $5.6B | 4.70% | |
| 7 | ORICORIC PHARMACEUTICALS INC | 485,629 | $4.9B | 4.10% | |
| 8 | REPLREPLIMUNE GROUP INC | 528,491 | $4.9B | 4.09% | |
| 9 | TARSTARSUS PHARMACEUTICALS INC | 121,182 | $4.9B | 4.08% | |
| 10 | IM8NINSMED INC | 47,710 | $4.8B | 4.00% | |
| 11 | BRD1EURMIND MEDICINE MINDMED INC | 726,172 | $4.7B | 3.92% | |
| 12 | GONGERON CORP | 3,251,475 | $4.6B | 3.81% | |
| 13 | CMPSCOMPASS PATHWAYS PLC | 1,485,000 | $4.2B | 3.46% | |
| 14 | CNTACENTESSA PHARMACEUTICALS PLC | 293,986 | $3.9B | 3.21% | |
| 15 | RNAAVIDITY BIOSCIENCES INC | 132,744 | $3.8B | 3.14% | |
| 16 | SLDBSOLID BIOSCIENCES INC | 724,000 | $3.5B | 2.93% | |
| 17 | LXEOLEXEO THERAPEUTICS INC | 867,302 | $3.5B | 2.90% | |
| 18 | PRAXPRAXIS PRECISION MEDICINES I | 80,880 | $3.4B | 2.83% | |
| 19 | TECXTECTONIC THERAPEUTIC INC | 163,683 | $3.3B | 2.71% | |
| 20 | KRROKORRO BIO INC | 154,223 | $1.9B | 1.60% | |
| 21 | WHWKWHITEHAWK THERAPEUTICS INC | 817,939 | $1.5B | 1.27% | |
| 22 | ATYRATYR PHARMA INC | 287,720 | $1.5B | 1.21% | |
| 23 | MNPRMONOPAR THERAPEUTICS INC | 34,537 | $1.2B | 1.03% | |
| 24 | PMNEURPROMIS NEUROSCIENCES INC | 1,334,428 | $645.6M | 0.54% |